Loading...
SCIg Therapy Adoption And Oncology Expansion Will Ultimately Disappoint Long-Term Expectations
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
34.4%7D
3.8%1Y
34.4%7D
3.8%You can edit this narrative until Dec 12 10:05 PM. Then, changes will post as Updates.